Last reviewed · How we verify
Induction Chemotherapy With TPF Followed by Radioimmunotherapy With Cetuximab and Intensity Modulated Radiotherapy (IMRT) Plus Carbon Ion Boost for Locally Advanced Tumors of the Oro-, Hypopharynx and Larynx: TPF-C-HIT
TPF-C-HIT investigates the combination of induction chemotherapy with TPF followed by radioimmunotherapy with cetuximab and IMRT plus carbon ion boost with regard to efficacy and toxicity of the combination regimen.
Details
| Lead sponsor | Heidelberg University |
|---|---|
| Phase | Phase 2 |
| Status | TERMINATED |
| Enrolment | 8 |
| Start date | 2010-11 |
| Completion | 2013-11 |
Conditions
- Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN): Oro-, Hypopharyngeal and Laryngeal Cancer
Interventions
- carbon ion boost
Primary outcomes
- Local-Regional Control (LRC) — 12 months
The primary endpoint of the study is the Local-Regional Control (LRC) at 1 year
Countries
Germany